We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
Increased
6
Reduced
3
Closed
920

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHC.WS
876
DELISTED
Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
LHC.WS
-85,543
Closed -$4K
FSNB.WS
877
DELISTED
Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FSNB.WS
-237,958
Closed -$15K
NOAC
878
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
-473,107
Closed -$4.73M
NOACW
879
DELISTED
Natural Order Acquisition Corp. Warrant
NOACW
-825,606
Closed -$8K
IS
880
DELISTED
ironSource Ltd.
IS
-11,038,395
Closed -$38M
HAAC
881
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
-656,992
Closed -$6.56M
HTAQ
882
DELISTED
Hunt Companies Acquisition Corp. I
HTAQ
-381,797
Closed -$3.88M
CLIM.WS
883
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
-123,562
Closed -$11K
EDNC
884
DELISTED
Endurance Acquisition Corp. Class A Ordinary Shares
EDNC
-919,138
Closed -$9.23M
LUXA
885
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
-237,619
Closed -$2.38M
PAQC
886
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
-974,837
Closed -$9.73M
TEKK
887
DELISTED
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
-232,020
Closed -$2.33M
TWTR
888
DELISTED
Twitter, Inc.
TWTR
-3,238,528
Closed -$142M
TWTR
889
PUT
DELISTED
Twitter, Inc.
TWTR
-455,100
Closed -$2.71M
BOAS
890
DELISTED
BOA Acquisition Corp.
BOAS
-374,325
Closed -$3.72M
ENPC
891
DELISTED
Executive Network Partnering Corporation
ENPC
-229,730
Closed -$2.29M
TMAC.WS
892
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
-167,918
Closed -$6K
LFTRW
893
DELISTED
Lefteris Acquisition Corp. Warrant
LFTRW
-158,411
Closed -$3K
LFTR
894
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
-475,238
Closed -$4.75M
HIGA
895
DELISTED
H.I.G. Acquisition Corp.
HIGA
-477,116
Closed -$4.79M
SANB
896
DELISTED
Sanaby Health Acquisition Corp. I Class A Common Stock
SANB
-267,649
Closed -$2.71M
CCXI
897
DELISTED
ChemoCentryx, Inc.
CCXI
-2,730,923
Closed -$141M
AVLR
898
DELISTED
Avalara, Inc.
AVLR
-4,065,318
Closed -$373M
PING
899
DELISTED
Ping Identity Holding Corp.
PING
-5,476,033
Closed -$154M
HTAQ.WS
900
DELISTED
Hunt Companies Acquisition Corp. I Warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 per share
HTAQ.WS
-190,898
Closed -$9K

Similar funds

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.